Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients.

about

Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients.

Item

http://www.wikidata.org/entity/Q38716033

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Network meta-analysis of lirag ...... diabetes in Japanese patients.

@en

type

Item

label

Network meta-analysis of lirag ...... diabetes in Japanese patients.

@en

prefLabel

Network meta-analysis of lirag ...... diabetes in Japanese patients.

@en

P1476

Network meta-analysis of lirag ...... diabetes in Japanese patients.

@en

P2093

Dieter Ayers

http://www.w3.org/2001/XMLSchema#string

Monica Hughes

http://www.w3.org/2001/XMLSchema#string

Nana Kragh

http://www.w3.org/2001/XMLSchema#string

Rachel Goldgrub

http://www.w3.org/2001/XMLSchema#string

Ryo Kato

http://www.w3.org/2001/XMLSchema#string

Steve Kanters

http://www.w3.org/2001/XMLSchema#string

P2860

A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks.

Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes.

Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus

Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes

Trends in the prevalence of type 2 diabetes and prediabetes in community-dwelling Japanese subjects: The Hisayama Study.

P304

1653-1661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1080/03007995.2017.1345730

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Steve Kanters

P577

2017-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28635331

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes